Stockholm Stock Exchange | Large Cap
Vitrolife
+56.43%
Latest
+46.10%
3 months
CarnegieSEBSEB EquitiesHandelsbankenDNBHandelsbanken Capital MarketsDNB Markets

Price Targets For Vitrolife

AnalystPrice TargetDateUpside
Carnegie265 SEKMar 20
+56.43%
SEB230 SEKMar 19
SEB Equities275 SEKOct -24
Handelsbanken250 SEKJul -24
DNB250 SEKJul -24
Handelsbanken Capital Markets220 SEKJan -24
DNB Markets220 SEKJan -24

About The Company

Vitrolife is a Swedish medtech company which sells products for IVF treatment.
Wikipedia